"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
Descriptor ID |
D008113
|
MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 2 | 2 |
1998 | 1 | 0 | 1 |
1999 | 4 | 1 | 5 |
2000 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 5 | 0 | 5 |
2003 | 7 | 5 | 12 |
2004 | 8 | 2 | 10 |
2005 | 4 | 2 | 6 |
2006 | 5 | 1 | 6 |
2007 | 3 | 2 | 5 |
2008 | 6 | 2 | 8 |
2009 | 5 | 1 | 6 |
2010 | 10 | 4 | 14 |
2011 | 15 | 2 | 17 |
2012 | 7 | 0 | 7 |
2013 | 7 | 0 | 7 |
2014 | 5 | 0 | 5 |
2015 | 12 | 2 | 14 |
2016 | 16 | 0 | 16 |
2017 | 12 | 2 | 14 |
2018 | 15 | 1 | 16 |
2019 | 6 | 2 | 8 |
2020 | 11 | 0 | 11 |
2021 | 7 | 0 | 7 |
2022 | 10 | 0 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Specific botanical groups of fruit and vegetable consumption and liver cancer and chronic liver disease mortality: a prospective cohort study. Am J Clin Nutr. 2023 02; 117(2):278-285.
-
Prenylated flavonoids with significant anti-hepatoma activity from Daphne giraldii and effects on Fibroblast Growth Factor Receptor 1 (FGFR1). Eur J Med Chem. 2023 Feb 05; 247:115006.
-
Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers. Adv Cancer Res. 2023; 157:57-81.
-
The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review. Clin Nutr. 2022 10; 41(10):2295-2307.
-
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. Prostate. 2022 09; 82(13):1264-1272.
-
FIB-4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine-Gray competing risk analysis. Liver Int. 2023 01; 43(1):170-179.
-
Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells. Biomed Pharmacother. 2022 Jun; 150:112928.
-
Unusual Radiotracer Deposition to the Forearm After Intrahepatic Injection of 99mTc-Macroaggregated Albumin Using a Transradial Approach. Clin Nucl Med. 2022 Apr 01; 47(4):e366-e367.
-
Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics. 2022 05; 21(5):100225.
-
Endohepatology - current status. Curr Opin Gastroenterol. 2022 05 01; 38(3):216-220.